Literature DB >> 2683800

Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.

J C Jennette1, A S Wilkman, R J Falk.   

Abstract

Anti-neutrophil cytoplasmic autoantibodies (ANCA) react with constituents of neutrophil primary granules and monocyte lysosomes. Indirect immunofluorescence microscopy using alcohol-fixed neutrophils demonstrates two ANCA types: one causing cytoplasmic staining (C-ANCA), and a second causing artifactual perinuclear staining (P-ANCA) that frequently has specificity for myeloperoxidase. Using indirect immunofluorescence microscopy (IIFM) and enzyme immunoassays (EIA), sera from over 300 patients with renal disease, with and without systemic vasculitis, were analyzed. Of 76 patients with pauci-immune glomerulonephritis with crescents or necrosis, 87% had ANCA by IIFM (38% of C-ANCA type, 49% of P-ANCA type), and 78% had ANCA by EIA. Of 55 patients with nonlupus immune complex-mediated glomerulonephritis, only 11% had ANCA by IIFM and 5% had ANCA by EIA. Of 24 patients with anti-GBM antibody-mediated glomerulonephritis, none had ANCA. Renal and extrarenal lesions were studied in 81 patients with ANCA-associated glomerulonephritis. These patients formed a pathologic continuum ranging from renal-limited to widespread systemic vascular injury, including patients with primary crescentic glomerulonephritis, Wegener's granulomatosis, and polyarteritis nodosa. In ANCA-positive patients the frequency of C-ANCA and P-ANCA correlated with disease distribution. P-ANCA was most frequent with renal-limited disease and C-ANCA was most frequent when there was lung and sinus involvement. It is proposed that ANCA are not only useful diagnostic markers, but may also be directly involved in a novel pathogenetic mechanism that is a frequent cause of crescentic glomerulonephritis and systemic necrotizing vasculitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2683800      PMCID: PMC1880110     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  Diagnostic significance of anticytoplasmatic antibodies (ACPA/ANCA) in detection of Wegener's granulomatosis and other forms of vasculitis.

Authors:  K Andrassy; J Koderisch; R Waldherr; M Rufer
Journal:  Nephron       Date:  1988       Impact factor: 2.847

2.  Antibodies to neutrophil cytoplasmic antigen in systemic vasculitis.

Authors:  M C Venning; S Arfeen; A G Bird
Journal:  Lancet       Date:  1987-10-10       Impact factor: 79.321

3.  Anticytoplasmic antibodies in Wegener's granulomatosis.

Authors:  W L Gross; G Lüdemann; G Kiefer; H Lehmann
Journal:  Lancet       Date:  1986-04-05       Impact factor: 79.321

4.  Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?

Authors:  D J Davies; J E Moran; J F Niall; G B Ryan
Journal:  Br Med J (Clin Res Ed)       Date:  1982 Aug 28-Sep 4

5.  Association of alkaline phosphatase with an autoantigen recognised by circulating anti-neutrophil antibodies in systemic vasculitis.

Authors:  C M Lockwood; D Bakes; S Jones; K B Whitaker; D W Moss; C O Savage
Journal:  Lancet       Date:  1987-03-28       Impact factor: 79.321

6.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

7.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

8.  Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis.

Authors:  U Specks; C L Wheatley; T J McDonald; M S Rohrbach; R A DeRemee
Journal:  Mayo Clin Proc       Date:  1989-01       Impact factor: 7.616

9.  Pathologic differentiation between lupus and nonlupus membranous glomerulopathy.

Authors:  J C Jennette; S S Iskandar; F G Dalldorf
Journal:  Kidney Int       Date:  1983-09       Impact factor: 10.612

10.  Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody.

Authors:  J B Hall; B M Wadham; C J Wood; V Ashton; W R Adam
Journal:  Aust N Z J Med       Date:  1984-06
View more
  73 in total

1.  Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis.

Authors:  R H Brons; M C de Jong; N K de Boer; C A Stegeman; C G Kallenberg; J W Tervaert
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

Review 2.  Immunopathological aspects of systemic vasculitis.

Authors:  I M Bajema; E C Hagen; F Ferrario; E de Heer; J A Bruijn
Journal:  Springer Semin Immunopathol       Date:  2001

3.  Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients.

Authors:  Zheng Tang; Dongmei Chen; Shengmei Yang; Haitao Zhang; Weixin Hu; Zhihong Liu; Leishi Li
Journal:  Rheumatol Int       Date:  2010-06-10       Impact factor: 2.631

Review 4.  The ANCA test: its clinical relevance.

Authors:  G Ramírez; M A Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

5.  Urinary podocyte mRNA is a potent biomarker of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Authors:  Akihiro Minakawa; Akihiro Fukuda; Masao Kikuchi; Yuji Sato; Yuichiro Sato; Kazuo Kitamura; Shouichi Fujimoto
Journal:  Clin Exp Nephrol       Date:  2019-11-25       Impact factor: 2.801

6.  Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.

Authors:  Hong Xiao; Adrian Schreiber; Peter Heeringa; Ronald J Falk; J Charles Jennette
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

7.  Antimyeloperoxidase antibodies in the Churg-Strauss syndrome.

Authors:  J W Tervaert; R Goldschmeding; J D Elema; A E von dem Borne; C G Kallenberg
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

8.  Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections.

Authors:  M C Gallicchio; J A Savige
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 9.  Antineutrophil cytoplasmic antibody--a useful serological marker for vasculitis.

Authors:  J A Goeken
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

10.  Anti-neutrophil cytoplasmic auto-antibodies-associated vasculitis with pulmonary and renal involvement.

Authors:  G Pintos-Morell; A Roca-Comas; M A Naranjo; C Tural; E Abad; G Javier; J Prats
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.